Most Recent
Pharmacor wants to amend its defence in AstraZeneca's suit over the Australian drug maker's plans to launch a generic version of diabetes drug Forxiga so that it can argue a patent extension for the drug should not have been granted.
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Acciona is mulling a bid to summarily dismiss a "hopelessly flawed" patent suit by its construction partner on the troubled East Rockingham waste-to-energy plant project, saying it is doomed in light of a High Court decision holding a patentee’s rights are exhausted at the time of sale.